These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Stecher B. Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088 [Abstract] [Full Text] [Related]
3. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease. Abdelbary MMH, Hatting M, Bott A, Dahlhausen A, Keller D, Trautwein C, Conrads G. Front Cell Infect Microbiol; 2022 Jun; 12():1010853. PubMed ID: 36275026 [Abstract] [Full Text] [Related]
5. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, Naito Y, Andoh A. J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861 [Abstract] [Full Text] [Related]
7. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders. Teofani A, Marafini I, Laudisi F, Pietrucci D, Salvatori S, Unida V, Biocca S, Monteleone G, Desideri A. Nutrients; 2022 Jan 08; 14(2):. PubMed ID: 35057440 [Abstract] [Full Text] [Related]
8. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, Spekhorst LM, Alberts R, Franke L, van Dullemen HM, Ter Steege RWF, Huttenhower C, Dijkstra G, Xavier RJ, Festen EAM, Wijmenga C, Zhernakova A, Weersma RK. Gut; 2018 Jan 08; 67(1):108-119. PubMed ID: 27802154 [Abstract] [Full Text] [Related]
10. Microbiome and its relevance to indigenous inflammatory bowel diseases in China. Han A, Yang M, Chen B, Cao G, Xu J, Meng T, Liu Y, Wang Z, Zhou Y, Xu N, Han W, Sun H, Mei Q, Zhu L, Xiong M. Gene; 2024 May 30; 909():148257. PubMed ID: 38367851 [Abstract] [Full Text] [Related]
12. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, Prince J, Kumar A, Sauer C, Zwick ME, Satten GA, Kostic AD, Mulle JG, Xavier RJ, Kugathasan S. Genome Med; 2016 Jul 13; 8(1):75. PubMed ID: 27412252 [Abstract] [Full Text] [Related]
15. Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population. Kim HS, Oh SJ, Kim BK, Kim JE, Kim BH, Park YK, Yang BG, Lee JY, Bae JW, Lee CK. Sci Rep; 2024 Oct 10; 14(1):23701. PubMed ID: 39390011 [Abstract] [Full Text] [Related]
16. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean. Rausch P, Ellul S, Pisani A, Bang C, Tabone T, Marantidis Cordina C, Zahra G, Franke A, Ellul P. Inflamm Bowel Dis; 2023 Jul 05; 29(7):1118-1132. PubMed ID: 36735955 [Abstract] [Full Text] [Related]
17. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases. Aden K, Rehman A, Waschina S, Pan WH, Walker A, Lucio M, Nunez AM, Bharti R, Zimmerman J, Bethge J, Schulte B, Schulte D, Franke A, Nikolaus S, Schroeder JO, Vandeputte D, Raes J, Szymczak S, Waetzig GH, Zeuner R, Schmitt-Kopplin P, Kaleta C, Schreiber S, Rosenstiel P. Gastroenterology; 2019 Nov 05; 157(5):1279-1292.e11. PubMed ID: 31326413 [Abstract] [Full Text] [Related]